Tulsa Wealth Advisors INC purchased a new position in CME Group Inc. (NASDAQ:CME – Free Report) in the 4th quarter, HoldingsChannel reports. The fund purchased 27,185 shares of the financial services provider’s stock, valued at approximately $7,424,000. CME Group comprises approximately 2.5% of Tulsa Wealth Advisors INC’s holdings, making the stock its 10th biggest position.
A number of other large investors have also modified their holdings of the stock. Caitong International Asset Management Co. Ltd grew its stake in CME Group by 169.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 803 shares of the financial services provider’s stock worth $219,000 after purchasing an additional 505 shares in the last quarter. Reflection Asset Management acquired a new stake in CME Group in the 4th quarter valued at about $95,000. Sankala Group LLC acquired a new stake in CME Group in the 4th quarter valued at about $116,000. OakTrust Wealth Advisors LLC purchased a new position in shares of CME Group in the 4th quarter valued at about $266,000. Finally, MidFirst Bank purchased a new position in shares of CME Group in the 4th quarter valued at about $514,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Analyst Upgrades and Downgrades
CME has been the topic of a number of recent research reports. Argus restated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Piper Sandler set a $320.00 price target on shares of CME Group in a report on Wednesday. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a research report on Thursday. Barclays reduced their price objective on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a report on Thursday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $305.18.
Insiders Place Their Bets
In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.
Trending Headlines about CME Group
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
- Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
- Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
- Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
- Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title
CME Group Price Performance
CME stock opened at $246.38 on Friday. The stock has a market cap of $89.28 billion, a P/E ratio of 21.02, a PEG ratio of 2.75 and a beta of 0.21. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $244.56 and a twelve month high of $329.16. The company’s 50 day moving average is $279.61 and its two-hundred day moving average is $287.21.
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.80 EPS. Research analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. CME Group’s payout ratio is 44.37%.
CME Group Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
- Five stocks we like better than CME Group
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
